Filing Details
- Accession Number:
- 0000937556-19-000130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-25 17:45:33
- Reporting Period:
- 2019-06-21
- Accepted Time:
- 2019-06-25 17:45:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403400 | Yongsam Lee | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Evp & Cio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-21 | 1,301 | $21.97 | 74,301 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-06-21 | 1,301 | $146.22 | 73,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-06-24 | 1,070 | $21.97 | 74,070 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-06-24 | 1,070 | $145.51 | 73,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2019-06-21 | 1,301 | $21.97 | 1,301 | $21.97 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2019-06-24 | 1,070 | $21.97 | 1,070 | $21.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,664 | 2014-05-28 | 2023-05-28 | No | 4 | M | Direct |
| 18,594 | 2014-05-28 | 2023-05-28 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 23, 2019, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $145.13 per share to a high of $147.04 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $145.00 per share to a high of $146.27 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on May 28, 2013 and is exercisable as it vested. This option vested over a five-year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Billionaire Hedge Funds
